Total Payments
$17,872
2024 Payments
$115.21
Companies
5
Transactions
30
Medicare Patients
1,139
Medicare Billing
$124,772
Payment Breakdown by Category
Other$12,983 (72.6%)
Travel$3,244 (18.2%)
Consulting$900.00 (5.0%)
Food & Beverage$636.59 (3.6%)
Education$108.39 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,713 | 7 | 54.3% |
| Honoraria | $3,270 | 1 | 18.3% |
| Travel and Lodging | $3,244 | 8 | 18.2% |
| Consulting Fee | $900.00 | 1 | 5.0% |
| Food and Beverage | $636.59 | 10 | 3.6% |
| Education | $108.39 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $10,370 | 14 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $3,809 | 6 | $0 (2023) |
| GlaxoSmithKline, LLC. | $2,776 | 8 | $0 (2020) |
| PFIZER INC. | $900.00 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $16.25 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.21 | 1 | Amgen Inc. ($115.21) |
| 2023 | $10,275 | 14 | Amgen Inc. ($10,255) |
| 2021 | $3,789 | 5 | Aurinia Pharma U.S., Inc. ($3,789) |
| 2020 | $1,500 | 1 | GlaxoSmithKline, LLC. ($1,500) |
| 2019 | $1,293 | 8 | GlaxoSmithKline, LLC. ($1,276) |
| 2017 | $900.00 | 1 | PFIZER INC. ($900.00) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $115.21 | General |
| 12/11/2023 | Amgen Inc. | TAVNEOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Inflammation | ||||||
| 12/11/2023 | Amgen Inc. | TAVNEOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Inflammation | ||||||
| 11/29/2023 | Amgen Inc. | TAVNEOS (Drug) | Travel and Lodging | In-kind items and services | $922.19 | General |
| Category: Inflammation | ||||||
| 11/27/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $106.78 | General |
| Category: Inflammation | ||||||
| 11/10/2023 | Amgen Inc. | TAVNEOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $787.50 | General |
| Category: Inflammation | ||||||
| 11/07/2023 | Amgen Inc. | TAVNEOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Inflammation | ||||||
| 11/07/2023 | Amgen Inc. | TAVNEOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Inflammation | ||||||
| 11/01/2023 | Amgen Inc. | TAVNEOS (Drug) | Travel and Lodging | In-kind items and services | $837.90 | General |
| Category: Inflammation | ||||||
| 10/25/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $65.40 | General |
| Category: Inflammation | ||||||
| 06/13/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: Inflammation | ||||||
| 04/14/2023 | Amgen Inc. | TAVNEOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,125.00 | General |
| Category: Inflammation | ||||||
| 04/13/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: Inflammation | ||||||
| 02/20/2023 | Amgen Inc. | TAVNEOS (Drug) | Education | In-kind items and services | $72.45 | General |
| Category: Inflammation | ||||||
| 01/30/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Education | In-kind items and services | $19.69 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/18/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Honoraria | Cash or cash equivalent | $3,270.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/18/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $146.33 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/18/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Travel and Lodging | Cash or cash equivalent | $126.56 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/18/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Travel and Lodging | In-kind items and services | $56.64 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/17/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Travel and Lodging | In-kind items and services | $189.67 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/06/2020 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2019 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $50.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2019 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $45.36 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2019 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $41.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2019 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 299 | 407 | $148,492 | $33,157 |
| 2022 | 4 | 248 | 340 | $110,843 | $27,518 |
| 2021 | 4 | 290 | 442 | $141,019 | $37,752 |
| 2020 | 5 | 302 | 408 | $115,018 | $26,345 |
Total Patients
1,139
Total Services
1,597
Medicare Billing
$124,772
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 166 | 239 | $79,074 | $17,131 | 21.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 76 | 100 | $45,717 | $11,063 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $7,786 | $1,741 | 22.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $6,948 | $1,723 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 17 | $3,995 | $890.63 | 22.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 22 | $4,972 | $607.78 | 12.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 136 | 201 | $60,212 | $14,936 | 24.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 71 | 95 | $38,312 | $9,832 | 25.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $5,947 | $1,411 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 31 | $6,372 | $1,340 | 21.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 155 | 260 | $73,953 | $19,112 | 25.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 95 | 141 | $54,420 | $15,453 | 28.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $7,155 | $1,772 | 24.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 28 | $5,491 | $1,414 | 25.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 140 | 209 | $55,630 | $12,383 | 22.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 86 | 117 | $42,005 | $9,831 | 23.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 46 | 51 | $9,589 | $1,852 | 19.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 13 | 13 | $5,756 | $1,270 | 22.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 17 | 18 | $2,038 | $1,009 | 49.5% |
About Donald Kimpel
Donald Kimpel is a Rheumatology healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700955325.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Donald Kimpel has received a total of $17,872 in payments from pharmaceutical and medical device companies, with $115.21 received in 2024. These payments were reported across 30 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,713).
As a Medicare-enrolled provider, Kimpel has provided services to 1,139 Medicare beneficiaries, totaling 1,597 services with total Medicare billing of $124,772. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Charlottesville, VA
- Active Since 11/07/2006
- Last Updated 08/10/2023
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1700955325
Products in Payments
- TAVNEOS (Drug) $10,255
- LUPKYNIS (Drug) $3,809
- BENLYSTA (Biological) $2,776
- XELJANZ (Drug) $900.00
- KEVZARA (Biological) $16.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Charlottesville
Peter Lipsky, M.d, M.D
Rheumatology — Payments: $1.4M
Rheumatology $1.4M
Jae Hee Yun, M.d, M.D
Rheumatology — Payments: $40,375
Rheumatology $40,375
Dr. Brian King, M.d, M.D
Rheumatology — Payments: $520.36
Rheumatology $520.36
Paul Katzenstein, M.d, M.D
Rheumatology — Payments: $349.47
Rheumatology $349.47
Janet Lewis
Rheumatology — Payments: $203.91
Rheumatology $203.91
Gitanjali Khurana, M.d, M.D
Rheumatology — Payments: $16.25
Rheumatology $16.25